Decade-Long study aims to unlock liver disease risks in HIV-Hepatitis b patients
NCT ID NCT02344680
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study follows adults in Zambia who have both HIV and chronic hepatitis B to track liver health over up to 10 years. Researchers aim to understand how current HIV treatments affect hepatitis B and liver damage, and to identify factors that lead to serious outcomes like liver cancer. The findings could help design future studies aimed at curing hepatitis B.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Anti-HIV Agents (antiretroviral therapy)
What this could lead to
If successful, this research could identify key risk factors for liver cancer and help design future studies for a hepatitis B cure.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly improve health. Results may take years and might not apply to other populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS, LIVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AWT020 for Advanced Cancers: Phase 1 Trial NCT06839105
- 68Ga-FAPI-46 PET Imaging in Cancer Patients (NCT07118176)
- Contrast Ultrasound vs. MRI for HCC Detection (NCT06184152)
- Liver Cancer Navigation Trial NCT06260943
- HIV, Aging & Vaccine Response Study NCT03729778
- Deep Multi-Omics Study in Liver Cancer (NCT05516628)
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre for Infectious Disease Research in Zambia (CIDRZ)
Lusaka, Lusaka Province, 34681, Zambia